Impact of major neonatal morbidities on adolescents born at 23-25 weeks of gestation
2018 (Engelska) Ingår i: Acta Paediatrica, ISSN 0803-5253, E-ISSN 1651-2227, Vol. 107, nr 11, s. 1893-1901Artikel i tidskrift (Refereegranskat) Published
Abstract [en]
Aim : More infants born extremely preterm (EPT) are surviving, but major neonatal morbidities are consistently high. This study examined the impact of bronchopulmonary dysplasia (BPD), brain injuries and severe retinopathy of prematurity (ROP) on adolescents who were born EPT.
Methods : We focused on EPT infants born at 23-25 weeks at the Swedish university hospitals in Uppsala and Umea from January 1992 to December 1998. The poor outcome data covered 140 of 142 who survived to 36 weeks, and the chronic conditions data reported by parents covered 132 of 134 still alive at 10-15 years.
Results : Of the 140 survivors at 36 weeks, 29 (21%) had poor outcomes: eight of 140 (6%) died, and 21 of 132 (16%) adolescent survivors had severe neurodevelopmental disabilities (NDD). BPD, severe ROP and/or brain injuries correlated independently with poor outcome. Of those adolescents who were free from BPD, brain injury and severe ROP, 6% had a severe NDD. The corresponding rates with any one, any two or all three neonatal morbidities were 21, 33 and 67%, respectively. BPD and brain injuries were associated with high rates of chronic conditions at 10-15 years of age resulting in functional limitations.
Conclusion : In adolescent EPT survivors, BPD and brain injuries were associated with high rates of chronic conditions and special healthcare needs.
Ort, förlag, år, upplaga, sidor John Wiley & Sons, 2018. Vol. 107, nr 11, s. 1893-1901
Nyckelord [en]
Chronic conditions, Extremely preterm infants, Long-term outcome, Neonatal morbidities, Neurodevelopmental outcome
Nationell ämneskategori
Pediatrik
Identifikatorer URN: urn:nbn:se:umu:diva-152972 DOI: 10.1111/apa.14445 ISI: 000446822800011 PubMedID: 29893052 Scopus ID: 2-s2.0-85050559978 OAI: oai:DiVA.org:umu-152972 DiVA, id: diva2:1260257
Forskningsfinansiär Västerbottens läns landsting, ALF-VLL 67971 Jerringfonden 2018-11-012018-11-012023-03-24 Bibliografiskt granskad